{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:54:46Z","timestamp":1760597686062},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Maxillofac Plast Reconstr Surg"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40902-016-0052-6","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T06:59:26Z","timestamp":1454309966000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients: a review of 25 cases"],"prefix":"10.1186","volume":"38","author":[{"given":"Hong-Joon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"key":"52_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12282-015-0609-8","volume":"23","author":"H Ito","year":"2016","unstructured":"Ito H, Matsuo K (2016) Molecular epidemiology, and possible real-world applications in breast cancer. Breast Cancer 23:33\u20138","journal-title":"Breast Cancer"},{"key":"52_CR2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ctrv.2012.02.002","volume":"38","author":"N Bundred","year":"2012","unstructured":"Bundred N (2012) Antiresorptive therapies in oncology and their effects on cancer progression. Cancer Treat Rev 38:776\u201386","journal-title":"Cancer Treat Rev"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00590-013-1293-z","volume":"25","author":"A Piccioli","year":"2015","unstructured":"Piccioli A (2015) Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer. Eur J Orthop Surg Traumatol 25:29\u201337","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"52_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-642-21892-7_3","volume":"192","author":"M Gnant","year":"2012","unstructured":"Gnant M, Dubsky P, Hadji P (2012) Bisphosphonates: prevention of bone metastases in breast cancer. Recent Results Cancer Res 192:65\u201391","journal-title":"Recent Results Cancer Res"},{"key":"52_CR5","volume-title":"Chapter 8. Bisphosphonate related osteonecrosis of the jaw in multiple myeloma. Multiple myeloma: risk factors, diagnosis and treatments","author":"KM Ahn","year":"2014","unstructured":"Ahn KM (2014) Chapter 8. Bisphosphonate related osteonecrosis of the jaw in multiple myeloma. Multiple myeloma: risk factors, diagnosis and treatments. Nova Science publishers, Inc., New York"},{"key":"52_CR6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u201334","journal-title":"J Oral Maxillofac Surg"},{"key":"52_CR7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1470-2045(08)70204-3","volume":"9","author":"M Gnant","year":"2008","unstructured":"Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kassmann H, Piswanger-Solkner JC et al (2008) Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. Lancet Oncol 9:840\u20139","journal-title":"Lancet Oncol"},{"key":"52_CR8","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","volume":"21","author":"BE Hillner","year":"2003","unstructured":"Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA et al (2003) American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21:4042\u201357","journal-title":"J Clin Oncol"},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","volume":"97","author":"GA Rodan","year":"1996","unstructured":"Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Invest 97:2692\u20136","journal-title":"J Clin Invest"},{"key":"52_CR10","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","volume":"83","author":"DE Hughes","year":"1989","unstructured":"Hughes DE, MacDonald BR, Russell RG, Gowen M (1989) Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 83:1930\u20135","journal-title":"J Clin Invest"},{"key":"52_CR11","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD et al (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478\u201387","journal-title":"J Bone Miner Res"},{"key":"52_CR12","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","volume":"91","author":"M Sahni","year":"1993","unstructured":"Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ (1993) Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 91:2004\u201311","journal-title":"J Clin Invest"},{"key":"52_CR13","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1532-5415.2011.03713.x","volume":"59","author":"J Shannon","year":"2011","unstructured":"Shannon J, Shannon J, Modelevsky S, Grippo AA (2011) Bisphosphonates and osteonecrosis of the jaw. J Am Geriatr Soc 59:2350\u20135","journal-title":"J Am Geriatr Soc"},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/cncr.11139","volume":"97","author":"JJ Body","year":"2003","unstructured":"Body JJ (2003) Effectiveness and cost of bisphosphonate therapy in tumor bone disease. Cancer 97:859\u201365","journal-title":"Cancer"},{"key":"52_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1634\/theoncologist.10-1-52","volume":"10","author":"JR Berenson","year":"2005","unstructured":"Berenson JR (2005) Recommendations for zoledronic acid treatment of patients with bone metastases. Oncologist 10:52\u201362","journal-title":"Oncologist"},{"key":"52_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02966406","volume":"7","author":"RE Coleman","year":"2000","unstructured":"Coleman RE (2000) Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM). Breast Cancer 7:361\u20139","journal-title":"Breast Cancer"},{"key":"52_CR17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20137","journal-title":"J Oral Maxillofac Surg"},{"key":"52_CR18","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72:1938\u201356","journal-title":"J Oral Maxillofac Surg"},{"key":"52_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbo.2015.09.001","volume":"4","author":"HR Kourie","year":"2015","unstructured":"Kourie HR, Antoun J, El Rassy E, Rassy M, Sader-Ghorra C, Kattan J (2015) Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: a literature review. J Bone Oncol 4:77\u20139","journal-title":"J Bone Oncol"},{"key":"52_CR20","doi-asserted-by":"crossref","unstructured":"Matsuo A, Hamada H, Takahashi H, Okamoto A, Kaise H, Chikazu D (2015) Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients. Odontology. [Epub ahead of print]","DOI":"10.1007\/s10266-015-0207-4"},{"key":"52_CR21","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1097\/MD.0000000000000671","volume":"94","author":"KN Pilanci","year":"2015","unstructured":"Pilanci KN, Alco G, Ordu C, Sarsenov D, Celebi F, Erdogan Z et al (2015) Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment? Medicine (Baltimore) 94:e671","journal-title":"Medicine (Baltimore)"},{"key":"52_CR22","volume-title":"American Joint Committee on Cancer, editors. AJCC cancer staging manual","author":"BD Edge SB","year":"2010","unstructured":"Edge SB BD, Compton CC, Fritz AG, Greene FL, Trotti A (2010) American Joint Committee on Cancer, editors. AJCC cancer staging manual, 7th edn. Springer, New York, NY","edition":"7"},{"key":"52_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2209\/tdcpublication.54.117","volume":"54","author":"T Nomura","year":"2013","unstructured":"Nomura T, Shibahara T, Uchiyama T, Yamamoto N, Shibui T, Yakushiji T et al (2013) Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic. Bull Tokyo Dent Coll 54:117\u201325","journal-title":"Bull Tokyo Dent Coll"},{"key":"52_CR24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M et al (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826\u201336","journal-title":"J Bone Miner Res"},{"key":"52_CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u201361","journal-title":"Ann Intern Med"},{"key":"52_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/mi.10.3.5","volume":"10","author":"MT Drake","year":"2010","unstructured":"Drake MT, Cremers SC (2010) Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition. Mol Interv 10:141\u201352","journal-title":"Mol Interv"},{"key":"52_CR27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2012.07.008","volume":"49","author":"D Holzinger","year":"2013","unstructured":"Holzinger D, Seemann R, Klug C, Ewers R, Millesi G, Baumann A et al (2013) Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs). Oral Oncol 49:66\u201370","journal-title":"Oral Oncol"},{"key":"52_CR28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coms.2014.01.009","volume":"26","author":"A Eid","year":"2014","unstructured":"Eid A, Atlas J (2014) The role of bisphosphonates in medical oncology and their association with jaw bone necrosis. Oral Maxillofac Surg Clin North Am 26:231\u20137","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"52_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10006-012-0376-z","volume":"18","author":"C Jacobsen","year":"2014","unstructured":"Jacobsen C, Zemann W, Obwegeser JA, Gratz KW, Metzler P (2014) The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of \u201cphossy\u201d and \u201cbisphossy\u201d jaw. Oral Maxillofac Surg 18:31\u20137","journal-title":"Oral Maxillofac Surg"},{"key":"52_CR30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1601-5037.2008.00331.x","volume":"7","author":"S Rayman","year":"2009","unstructured":"Rayman S, Almas K, Dincer E (2009) Bisphosphonate-related jaw necrosis: a team approach management and prevention. Int J Dent Hyg 7:90\u20135","journal-title":"Int J Dent Hyg"},{"key":"52_CR31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613\u201320","journal-title":"J Bone Miner Res"},{"key":"52_CR32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40902-015-0020-6","volume":"37","author":"HW Jang","year":"2015","unstructured":"Jang HW, Kim JW, Cha IH (2015) Development of animal model for bisphosphonates-related osteonecrosis of the jaw (BRONJ). Maxillofac Plast Reconstr Surg 37:18","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"52_CR33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/cid.12048","volume":"16","author":"Y Tam","year":"2014","unstructured":"Tam Y, Kar K, Nowzari H, Cha HS, Ahn KM (2014) Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates\u2014a presentation of six consecutive cases. Clin Implant Dent Relat Res 16:751\u201361","journal-title":"Clin Implant Dent Relat Res"},{"key":"52_CR34","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.joms.2012.05.019","volume":"70","author":"F Graziani","year":"2012","unstructured":"Graziani F, Vescovi P, Campisi G, Favia G, Gabriele M, Gaeta GM et al (2012) Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases. J Oral Maxillofac Surg 70:2501\u20137","journal-title":"J Oral Maxillofac Surg"},{"key":"52_CR35","first-page":"174","volume":"35","author":"M-KK Jang-Ha Lee","year":"2013","unstructured":"Jang-Ha Lee M-KK, Kim S-G, Park Y-W, Park S-W, Park Y-J (2013) Surgical management of bisphosphonate related osteonecrosis of the jaw using pedicled buccal fat pad flap. J Korean Assoc Maxillofac Plast Reconstr Surg 35:174\u20137","journal-title":"J Korean Assoc Maxillofac Plast Reconstr Surg"},{"key":"52_CR36","first-page":"302","volume":"35","author":"MHS Ho Kyung Lee","year":"2013","unstructured":"Ho Kyung Lee MHS, Pang KM, Song SI, Lee JK (2013) Comparative study on surgical and conservative management of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in disease stage 2. J Korean Assoc Maxillofac Plast Reconstr Surg 35:302\u20139","journal-title":"J Korean Assoc Maxillofac Plast Reconstr Surg"},{"key":"52_CR37","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.22991","volume":"110","author":"F Saad","year":"2007","unstructured":"Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R (2007) Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 110:1860\u20137","journal-title":"Cancer"}],"container-title":["Maxillofacial Plastic and Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40902-016-0052-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40902-016-0052-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40902-016-0052-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T12:07:59Z","timestamp":1553602079000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jkamprs.com\/content\/38\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1186\/s40902-016-0052-6","relation":{},"ISSN":["2288-8586"],"issn-type":[{"value":"2288-8586","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]},"article-number":"6"}}